ARTICLE
28 April 2015

OIG Provides Additional Compliance Guidance For Healthcare Governing Boards

B
BakerHostetler

Contributor

BakerHostetler logo
Recognized as one of the top firms for client service, BakerHostetler is a leading national law firm that helps clients around the world address their most complex and critical business and regulatory issues. With five core national practice groups — Business, Labor and Employment, Intellectual Property, Litigation, and Tax — the firm has more than 970 lawyers located in 14 offices coast to coast. BakerHostetler is widely regarded as having one of the country’s top 10 tax practices, a nationally recognized litigation practice, an award-winning data privacy practice and an industry-leading business practice. The firm is also recognized internationally for its groundbreaking work recovering more than $13 billion in the Madoff Recovery Initiative, representing the SIPA Trustee for the liquidation of Bernard L. Madoff Investment Securities LLC. Visit bakerlaw.com
The guidance acknowledges compliance programs are not uniform, as the design of a compliance program takes into account factors such as the size and complexity of the organization.
United States Food, Drugs, Healthcare, Life Sciences

On April 20, 2015, the HHS Office of Inspector General (HHS OIG), in collaboration with the American Health Lawyers Association (AHLA), the Association of Healthcare Internal Auditors (AHIA), and the Health Care Compliance Association (HCCA), released a guidance document on compliance for healthcare governing boards, attorneys, compliance officers, and internal auditors. The insight provided by the government, along with various industry leaders, highlights the cross-disciplinary effort required to create and maintain a culture of corporate compliance for healthcare entities in order to protect the integrity and viability of the nation's healthcare delivery system.

In light of increasing government fraud and abuse enforcement activity, governing boards have several incentives to build and maintain strong compliance programs that both prevent compliance failures and encourage self-identification of compliance failures for purposes of voluntary disclosure to avoid False Claims Act or civil monetary penalty liability.

Titled "Practical Guidance for Health Care Governing Boards on Compliance Oversight," the document expands on prior guidance issued by HHS OIG and AHLA in this area and covers the following topics:

  • Expectations for board oversight of compliance program functions
  • Roles and relationships
  • Reporting to the board
  • Identifying and auditing potential risk areas
  • Encouraging accountability and compliance

The issuing organizations make clear that healthcare governing board members should make efforts (1) to increase their knowledge of regulatory risks and the role and operations of their organization's compliance program in handling those risks, and (2) to ensure the appropriate flow and elevation of reporting of potential issues and problems to management. The guidance acknowledges compliance programs are not uniform, as the design of a compliance program takes into account factors such as the size and complexity of the organization.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More